US Patent 11851445 Compounds and uses thereof
Patent 11851445 was granted and assigned to Foghorn Therapeutics on December, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11851445 Compounds and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
